In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Magnesium Glycerophosphate Drug Master File in Korea (Magnesium Glycerophosphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Magnesium Glycerophosphate. The MFDS reviews the Magnesium Glycerophosphate KDMF as part of the drug registration process and uses the information provided in the Magnesium Glycerophosphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Magnesium Glycerophosphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Magnesium Glycerophosphate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Magnesium Glycerophosphate suppliers with KDMF on PharmaCompass.